ライフサイエンスコーパス: low income

1 munities of color, rural areas, and areas of low income.

2 were mostly living with family (95%) and had low incomes.

3 individuals remained for analysis, from five low-income, 11 middle-income, and four high-income count

4 880 [56%] were non-Hispanic white), 32% were low-income, 12% were low-middle-income, and 56% were mid

5 re would yield the largest survival gains in low-income (2.5-3.4 percentage point increase in surviva

6 frican-American (68%) or Hispanic (16%), and low income (48% reported <$12,000/y), with a median age

7 pulation was predominantly black (79.4%) and low income (66.3% [<$30,000]).

8 ample included 847,413 adults in 28 LMICs (8 low income, 9 lower-middle income, 11 upper-middle incom

9 A cohort of 1,241,351 low-income adults (observed January 2010-December 2016;

10 ACEs were more prevalent in low-income adults compared with previous estimates in a

11 Recent studies have reported that low-income adults living in more affluent areas of the U

12 For low-income adults with uncontrolled asthma, portal acces

13 d expansion extended coverage to millions of low-income adults.

14 Rwanda was the first low-income African country to introduce RotaTeq vaccine

15 in 660 urine samples from 148 predominantly low-income, African American children (aged 5-17 years)

16 onth, SNAP provides assistance to 40 million low-income Americans-nearly half of them children.

17 le of cardiovascular disease differs between low-income and high-income countries.

18 with stunting due to these infections in 79 low-income and lower middle-income countries.

19 ted burden occurs among young infants and in low-income and lower middle-income countries.

20 ential threats to nutrition, particularly in low-income and lower-middle income countries where the m

21 cination and cervical screening scenarios in low-income and lower-middle-income countries (LMICs) to

22 sed rates of cervical cancer mortality in 78 low-income and lower-middle-income countries (LMICs) wer

23 atios of $94 per HLYG (95% UI 73-123) across low-income and lower-middle-income countries and $237 pe

24 Infants younger than 6 months in low-income and lower-middle-income countries are at grea

25 nger than 6 months, of which 79% occurred in low-income and lower-middle-income countries.

26 tal, 9.3 million children (84.1%) will be in low-income and lower-middle-income countries.

27 use pneumonia mortality data in six sites in low-income and lower-middle-income countries.

28 ut 82% of the in-hospital deaths occurred in low-income and lower-middle-income countries.

29 virus-associated ALRI among young infants in low-income and lower-middle-income countries.

30 Low-income and middle-income countries (LMICs) face majo

31 To support low-income and middle-income countries (LMICs) in their

32 ce from nationally representative studies in low-income and middle-income countries (LMICs) on where

33 Currently, only 44% of newborn babies in low-income and middle-income countries (LMICs) receive a

34 The burden of stroke is higher in low-income and middle-income countries (LMICs) than in h

35 le fractions (PAFs) for dementia in selected low-income and middle-income countries (LMICs) to identi

36 orld's incarcerated individuals are based in low-income and middle-income countries (LMICs), the burd

37 In low-income and middle-income countries (LMICs), the limi

38 However, most people with dementia live in low-income and middle-income countries (LMICs), where de

39 cal precancer in see-and-treat programmes in low-income and middle-income countries (LMICs).

40 ffic deaths by 2020, will not be met by most low-income and middle-income countries (LMICs).

41 lbirths occur each year, 98% of which are in low-income and middle-income countries (LMICs).

42 hnicity and child survival have been done in low-income and middle-income countries (LMICs).

43 of disease in adolescents, especially among low-income and middle-income countries (LMICs).

44 fibrosis between high-income countries, and low-income and middle-income countries (LMICs).

45 ted in both high-income countries (HICs) and low-income and middle-income countries (LMICs).

46 nd access to patented essential medicines in low-income and middle-income countries (LMICs).

47 ion and overweight and obesity, affects most low-income and middle-income countries (LMICs).

48 with HIV-related cryptococcal meningitis in low-income and middle-income countries (LMICs): optimise

49 ith the burden overwhelmingly experienced in low-income and middle-income countries (LMICs; 60.8 mill

50 Oral vaccines underperform in low-income and middle-income countries compared with in

51 Female sex workers in low-income and middle-income countries face high risks o

52 umber of COVID-19 cases was projected for 73 low-income and middle-income countries for each of the t

53 Low-income and middle-income countries had the highest d

54 Despite this substantial burden, only a few low-income and middle-income countries have adopted rout

55 Although low-income and middle-income countries have the largest

56 tudies examining measles cases and deaths in low-income and middle-income countries in all age groups

57 ecision making on PCV introduction for other low-income and middle-income countries in the region.

58 s, but the burden of pneumococcal disease in low-income and middle-income countries is dominated by p

59 Transportation of laboratory samples in low-income and middle-income countries is often constrai

60 mplementation of mental health programmes in low-income and middle-income countries is scarce.

61 The effect of lockdowns in low-income and middle-income countries must be understoo

62 Health-care resource constraints in low-income and middle-income countries necessitate the i

63 Although aid for RMNCH increased in 2017, low-income and middle-income countries still experience

64 proximately 90% of cervical cancers occur in low-income and middle-income countries that lack organis

65 Most of the world's adolescents live in low-income and middle-income countries where tuberculosi

66 the 43% of children younger than 5 years in low-income and middle-income countries who have compromi

67 rvices for HIV, tuberculosis, and malaria in low-income and middle-income countries with high burdens

68 Economic recession might worsen health in low-income and middle-income countries with precarious j

69 navir (a protease inhibitor commonly used in low-income and middle-income countries) for individuals

70 n within constrained hardware (especially in low-income and middle-income countries), can directly co

71 e disease that still commonly occurs in many low-income and middle-income countries, although it is r

72 es have risen substantially, particularly in low-income and middle-income countries, and further incr

73 gap between need and supply is large in many low-income and middle-income countries, and reinforce th

74 istics on PCMC in four settings across three low-income and middle-income countries, and we examine k

75 Although many cases of HIV are in low-income and middle-income countries, high-quality epi

76 long-term prognosis after a first stroke in low-income and middle-income countries, including China.

77 parous women with singleton pregnancies from low-income and middle-income countries, low-dose aspirin

78 ertable mortality from NCDs was clustered in low-income and middle-income countries, mainly in the So

79 is and access to treatment remain crucial in low-income and middle-income countries, primary preventi

80 newborn survival have been achieved in many low-income and middle-income countries, reductions in st

81 e surgery is rarely needed; in any event, in low-income and middle-income countries, resources for ex

82 ehensively avert NCD burden, particularly in low-income and middle-income countries, the availability

83 acute rotavirus gastroenteritis in primarily low-income and middle-income countries, using 9 years of

84 hallenge will be to enable these advances in low-income and middle-income countries, where disease pr

85 ountries to resource limited environments in low-income and middle-income countries, where rates of c

86 V, have not been systematically evaluated in low-income and middle-income countries, where the diseas

87 Parasitoses are widely prevalent in low-income and middle-income countries, which are home t

88 xiety and depression after armed conflict in low-income and middle-income countries, yet few scalable

89 r-5 child deaths under each scenario, in 118 low-income and middle-income countries.

90 tion to prevent anaemia in young children in low-income and middle-income countries.

91 ty, with a disproportionately high burden in low-income and middle-income countries.

92 ng the leading causes of death by suicide in low-income and middle-income countries.

93 in HIV-positive populations, particularly in low-income and middle-income countries.

94 responsive and respectful maternity care-in low-income and middle-income countries.

95 disorders at primary health-care settings in low-income and middle-income countries.

96 ns as first-line treatment for depression in low-income and middle-income countries.

97 to engage key population at risk for HIV in low-income and middle-income countries.

98 .5 million DALYs, with the highest burden in low-income and middle-income countries.

99 m future immunisation policy particularly in low-income and middle-income countries.

100 83% of these deaths will occur in low-income and middle-income countries.

101 stakeholders on formulations most needed for low-income and middle-income countries.

102 d types of cups or unknown) and 15 were from low-income and middle-income countries.

103 ght to ensure supply, quality, and safety in low-income and middle-income countries.

104 evention, diagnosis, and treatment of HIV in low-income and middle-income countries.

105 health threat has been slow, particularly in low-income and middle-income countries.

106 death among children younger than 5 years in low-income and middle-income countries.

107 e not universally available, particularly in low-income and middle-income countries.

108 affecting a large number of individuals from low-income and middle-income countries.

109 s to implementing integrated chronic care in low-income and middle-income countries; and the practica

110 th-care system, with often limited supply in low-income and middle-income countries; however, the deg

111 grating care in high-income countries and in low-income and middle-income countries; the key organisa

112 ility, and safety of rapid ART initiation in low-income and middle-income country settings.

113 ations (99 [80%] of which were classified as low-income and middle-income) met the inclusion criteria

114 ection, the paucity of internet access among low-income and minority communities may reduce the diver

115 nmental health interventions and services in low-income and resource-limited settings-such as water s

116 practitioners and primary care physicians in low-income and rural areas.

117 y to reside in a census tract that is rural, low income, and from areas outside the Northeast.

118 promotion intervention delivered in an urban low-income area of Colombia (phase 1) and to assess the

119 rance (Medicare or Medicaid), residence in a low-income area, and obesity were associated with increa

120 and their mothers from an ongoing cohort of low-income Chilean girls born from 2002-2003.

121 lf-sustainable operation and job creation in low-income communities (<$2/day/capita).

122 a common clinical concern among children in low-income communities affected by human immunodeficienc

123 g children at primary health care centers in low-income communities in Karachi, Pakistan.

124 owder (FMP) to satisfy the growing demand of low-income consumers for dairy proteins in the developin

125 ultrasound would yield the largest gains in low-income countries (0.5, 0.0-3.7), expanding CT and x-

126 gions, with the largest proportional rise in low-income countries (155% increase between 2016 and 206

127 -year net survival by more than ten times in low-income countries (3.8% [95% UI 0.5-9.2] to 45.2% [40

128 re likely to be women (35.4%) and to be from low-income countries (47.7%) (predominantly in South/Sou

129 e largest absolute percentage point gains in low-income countries (5.2, 0.3-13.5), and expanding surg

130 sease from 21 high-income, middle-income, or low-income countries (HICs, MICs, or LICs).

131 ividual component costs of these packages in low-income countries (LICs) and lower-middle-income coun

132 (HICs), middle-income countries (MICs), and low-income countries (LICs) with standardised approaches

133 le-income countries, and 2.76 (2.29-3.31) in low-income countries (p(interaction)<0.0001).

134 eased as the level of education increased in low-income countries (p(interaction)<0.0001).

135 verwhelming majority of poultry producers in low-income countries - tend to rely on rapid sale of bir

136 graphic region (high-income countries 64.5%, low-income countries 9.1%), type of ICU (neonatal 67.0%,

137 e Americas, which disproportionately affects low-income countries and is likely to result in undertre

138 s likely to be underestimated, and data from low-income countries are needed to inform the public hea

139 interventions implemented in rural areas in low-income countries are unlikely to reduce stunting or

140 As many low-income countries begin to reach the threshold at whi

141 se in modifying various health behaviours in low-income countries but few studies have assessed wheth

142 revalence of vaccine-preventable diseases in low-income countries even when there are means to combat

143 In addition, patients from low-income countries frequently receive inappropriate tr

144 Low-income countries have reduced health care system cap

145 The proportion of aid for RMNCH received by low-income countries increased from 31% in 2002 to 52% i

146 anagement at the primary healthcare level in low-income countries is unknown.

147 nd distribution systems for bioherbicides in low-income countries may have potential as an inexpensiv

148 Between 1990 and 2017, low-income countries observed large reductions in the ag

149 deficiency virus (HIV) treatment programs in low-income countries often delays detection of treatment

150 Undernourished children in low-income countries often exhibit poor responses to ora

151 l disease in high-income, middle-income, and low-income countries present unprecedented challenges fo

152 e implementation of chlorine disinfection in low-income countries reduces the risk of waterborne illn

153 Most caretakers of children with diarrhea in low-income countries seek care in the private sector whe

154 Low-income countries tended to have higher prevented fra

155 and affordable malaria control solution for low-income countries that are losing protection in the f

156 Like high-income countries, low-income countries typically are adopting regulations

157 saving treatment, especially for patients in low-income countries where the clinical need is greatest

158 although it is likely that comorbidities in low-income countries will also influence disease severit

159 ion of sampling sites, which is difficult in low-income countries with informal sewage networks.

160 imes reflects low service coverage (often in low-income countries) but sometimes occurs despite high

161 prevalence in 2016 was 84.9% (82.6-88.2) in low-income countries, 79.3% (77.2-87.5) in lower-middle-

162 income decile (<$450 per person per year) in low-income countries, a unit increase in the trade polic

163 060, with the fastest increases occurring in low-income countries, among older people, and people wit

164 differ among high-income, middle-income, and low-income countries, and, if so, why these differences

165 ventilation during neonatal resuscitation in low-income countries, but whether the use of an LMA redu

166 In low-income countries, care for people with mental, neuro

167 In both high- and low-income countries, HIV-negative children born to HIV-

168 In low-income countries, monitoring all drinking water supp

169 In low-income countries, reduction of transmission is of pa

170 greater inclusion of diverse ancestries and low-income countries, the closer integration of psychiat

171 on of DBP species other than THM4 is rare in low-income countries, where water sources may be degrade

172 te vaccine more accessible and affordable in low-income countries, which will allow the vaccine to of

173 h younger population structures-such as many low-income countries-the expected per capita incidence o

174 l and reproductive health care than those in low-income countries.

175 challenges of populations in both high- and low-income countries.

176 COVID-19 forecasting models when applied to low-income countries.

177 ss epidemiologic trends for 194, middle, and low-income countries.

178 e burden, especially among young children in low-income countries.

179 reat problem in public health, especially in low-income countries.

180 prevalence of pre-eclampsia and eclampsia in low-income countries.

181 in the surgical management of miscarriage in low-income countries.

182 ypes of country studied, but much more so in low-income countries.

183 pairs across high-income, medium-income, and low-income countries.

184 rotavirus vaccine, but data are lacking from low-income countries.

185 s vaccination to be highly cost-effective in low-income countries.

186 omic burden in high-income countries than in low-income countries.

187 of allergy-related diseases is increasing in low-income countries.

188 rity among the world's poorest households in low-income countries.

189 he adoption of this affordable technology in low-income countries.

190 g women with pregnancy hypertension in three low-income countries.

191 work in high-income versus middle-income and low-income countries.

192 th, including 12% of the total population in low-income countries.

193 and lower-middle-income countries but not in low-income countries.

194 meeting this commitment in urban settings of low-income countries.

195 overused almost everywhere, both in high and low-income countries.

196 s, however, can be expensive to implement in low-income countries.

197 of 12 times (range 4-17) higher than that in low-income countries.

198 % showing that intensification of dairy in a low-income country can increase milk yields without incr

199 easles vaccination as well as morbidity in a low-income country.

200 anging demographics and RSV seasonality of a low-income country.

201 Low-income environments have been associated with greate

202 or medical and dental care for children from low-income families and support nondental primary care p

203 er are generally self-built neighborhoods of low-income families that lack basic infrastructure.

204 h preschool classrooms serving children from low-income families with an evidence-based social-emotio

205 loping countries, least developed countries, low-income food deficit countries, and net food-importin

206 ed among landlocked developing countries and low-income food deficit countries, with significant nutr

207 e (67%), aged 21 to 44 years (46%), and from low-income households (32%).

208 ge the gap between the willingness-to-pay of low-income households and actual market prices of toilet

209 A charity granted low-income households debt relief worth up to Singapore

210 five cities, and we surveyed a total of 2381 low-income households to estimate willingness-to-pay.

211 ulnerable groups and, including adolescents, low-income households, and several racial/ethnic minorit

212 This reform allowed low-income immigrants eligible for citizenship to use a

213 s an important obstacle to citizenship among low-income immigrants who demonstrate an interest in nat

214 inequality increases financial hardship for low-income individuals by reducing their ability to rely

215 e Act expanded Medicaid eligibility allowing low-income individuals greater access to health care.

216 with an increase of financial hardship among low-income individuals of 0.10 s.d.

217 t, because a frayed community buffer reduces low-income individuals' propensity to seek informal fina

218 nately intensifies the financial hardship of low-income individuals.

219 Reviews also confirm qualitatively that low income is associated with periodontal disease and po

220 chools with a disproportionate enrollment of low-income Latino students.

221 and risk factors amongst Syrian refugees and low-income Lebanese mothers accessing a primary care cen

222 in dietary quality for lunch among presumed low-income, low-middle-income, and middle-high-income pa

223 ng system in a primary care clinic serving a low-income metropolitan patient population improved adhe

224 suggest that BPA exposure in a predominantly low-income, minority pediatric cohort is associated with

225 sing data from a prospective study of young, low-income mothers who survived Hurricane Katrina, we fi

226 voided asthma emergency department visits in low-income neighborhoods as compared to the wealthiest n

227 y store chain (DVS) that is often located in low-income neighborhoods became an authorized WIC vendor

228 les and the availability of healthy foods in low-income neighborhoods.

229 home substantially more than individuals in low-income neighbourhoods did.

230 Residents of low-income neighbourhoods were more likely to work outsi

231 ated with small increases in staying home in low-income neighbourhoods.

232 e of NO(x) (=NO + NO(2)) emission sources in low-income, non-white, and Hispanic neighborhoods.

233 d and a disproportionate share is located in low-income, non-white, and Hispanic neighborhoods.

234 The sample consisted of 12 229 low-income, nonelderly uninsured adults who participated

235 are concentrating in the city centre, while low-income occupations are pushed to urban peripheries.

236 income occupations, accompanied by a fall in low-income occupations in all three cities, providing st

237 countries with a high burden of malaria are low income or lower-middle income, mobilising additional

238 , or certain socioeconomic risk factors (eg, low income or young or single parenthood) would benefit

239 e response to a pandemic can be mounted in a low-income or middle-income country.

240 cked insurance, were non-Hispanic black, had low income, or had high-comorbidity burden were at highe

241 Low-income patients are particularly likely to defer car

242 Low-income patients eligible for cost-sharing and premiu

243 and Main Results: In multivariate analysis, low-income patients had significantly higher rates of ne

244 Among low-income patients, Marketplace implementation was asso

245 ractice or to address specific cost needs of low-income patients.

246 ts in advance and disproportionately affects low-income patients.

247 of-care conversations between clinicians and low-income patients.

248 Programs (ADAPs) are associated with VS for low-income people living with HIV (PLWH) across 3 states

249 Programs (ADAPs) are associated with VS for low-income people living with HIV (PLWH) across three st

250 This study characterizes net dollars low-income persons received from participation in tax pr

251 ce of a geographic area and morbidity of the low-income population.

252 the incomplete take-up of public benefits by low-income populations(4-10) and suggest that lack of in

253 ension prevention and control, especially in low-income populations, and to accurately assess the pre

254 a high percentage of the patients were from low-income populations.

255 fect on height of 0.879 cm (0.821-0.932) for low-income populations.

256 SMSXXI covers uninsured, primarily low-income, populations who might be most at risk of the

257 ildren, sexual activity, household crowding, low income) probably increase the risk of acquisition of

258 gy to improve the reach of cancer therapy to low income regions with such new tricks of old drugs.

259 ty, particularly in patients with HFrEF from low-income regions with high income inequality.

260 reases in non-communicable disease burden in low-income, remote, and Indigenous communities.

261 on account of their Black, foreign-born, or low-income residents.

262 T practices (including bottled water use) in low-income rural areas in two Chinese provinces, evaluat

263 ional intervention deliverable at scale in a low-income setting resulted in substantial increases in

264 , though population incidence estimates from low income settings, including sub-Saharan Africa (sSA),

265 nd infection risk for different pathogens in low income settings.

266 oaches to antimicrobial stewardship (AMS) in low-income settings are not well studied.

267 n drives vascular dysfunction in HIV, but in low-income settings causes of inflammation are multiple,

268 lation structure but are rarely conducted in low-income settings despite the high disease burden.

269 f household water treatment interventions in low-income settings have failed to detect a reduction in

270 ubstantial direct and indirect protection in low-income settings in tropical Africa.

271 The burden of norovirus disease in low-income settings is poorly understood.

272 s a leading cause of death among neonates in low-income settings, a situation that is deteriorating d

273 although population incidence estimates from low-income settings, including sub-Saharan Africa, are a

274 es estimated to provide the largest gains in low-income settings, while MRI and PET would yield the l

275 a major source of morbidity and mortality in low-income settings.

276 mes and to study implementation in rural and low-income settings.

277 es and movement declines 40% more rapidly in low-income settings.

278 ions for childhood mortality particularly in low-income settings.

279 can be integrated into HIV care programs in low-income settings.

280 dinal studies, which are rarely available in low-income settings.

281 icality, acceptability, and affordability in low-income settings.

282 sions of AMS interventions in this and other low-income settings.

283 emiology and drug resistance surveillance in low-income settings.

284 can be integrated into HIV-care programs in low-income settings.

285 In study 1, residents of low-income settlements in Nairobi, Kenya (N = 565) recei

286 debt, housing instability, unemployment, and low income) should be considered for optimal assessment,

287 Low-income status measured on the basis of receipt of Me

288 Among low-income students, the adjusted mean prepolicy HEI-201

289 d on the basis of receipt of Medicare Part D low-income subsidies and not capturing persons not enrol

290 icity, disability, enrollment in Medicaid or low-income subsidies, managed care enrollment, region an

291 ted with improved financial protection among low-income surgical patients eligible for both cost-shar

292 The analysis involved 14 countries spanning low-income to high-income settings, and cost-effectivene

293 NO(2) for non-whites and Hispanics living in low-income tracts (LIN) compared to whites living in hig

294 ions about costs of care in settings serving low-income, uninsured Latino populations.

295 likely to have poor oral health if they are low-income, uninsured, and/or members of racial/ethnic m

296 Number of symptoms and low income were associated with decreased quality of lif

297 Further study of residential indoor air in low-income women's homes in this area is needed.

298 f the benefits of recent WIC revisions among low-income women.

299 that refuse to expand insurance coverage to low-income workers through the Affordable Care Act; (3)

300 than the privately insured, and patients in low-income ZIP codes were less likely than those in high